HIRANI+logo.jpg

Interim Chief Executive Officer

HIRANI

Contract type: 12-month fixed-term appointment, with potential extension subject to funding and Board approval
Salary: Competitive and commensurate with experience; pro rata where applicable
Closing date: 7 October 2026 12:00pm

The Interim Chief Executive Officer will provide visible and effective leadership during a period of organisational transition. The postholder will maintain staff stability and delivery of HIRANI’s existing commitments, while working closely with the Board, funders and stakeholders to clarify HIRANI’s future positioning, operating model and funding base.

Pharmaron+Logo+-+Color+%28600+dpi%29.jpg

Senior Manager (Separation and Characterisation Sciences)

Pharmaron

Closing date: 23 October 2026 12:00am
Logo+with+extra+spacing.png

Founder's Associate & Operations Lead

AlphaVectors Biotech (AVB)

Salary: £50,000 to £55,000 FTE (£20,000 to £22,000 actual, part-time 2 days/week), plus share options
Closing date: 28 February 2027 12:00am